BRCA1
Tumor suppressor gene; germline and somatic mutations confer sensitivity to PARP inhibitors. Important in breast, ovarian, prostate, pancreatic cancers.
No Clinical Trials found for this biomarker.
Tumor suppressor gene; germline and somatic mutations confer sensitivity to PARP inhibitors. Important in breast, ovarian, prostate, pancreatic cancers.
No Clinical Trials found for this biomarker.